View Older Stories View More Recent Stories

Sep 24, 2026 12:18PM Citi cuts Acadia Pharmaceuticals price target to $33
Sep 24, 2026 12:16PM Acadia Pharmaceuticals (ACAD) PT Lowered to $34 at BMO Capital Amid Heavy Selling
Sep 24, 2026 10:02AM Acadia Pharmaceuticals drops on trial miss
Sep 23, 2026 05:24AM Oppenheimer Reiterates Perform Rating on Acadia Pharmaceuticals (ACAD)
Sep 21, 2026 06:03AM Increasing unusual option volume: UTHR ABUS OPRA GFL ACAD
Sep 15, 2026 10:01AM Increasing unusual option volume: ACAD ALHC PLAY FPS ITUB NAVN WVE UAL XEL
Sep 3, 2026 06:44AM Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
Aug 25, 2026 06:57AM H.C. Wainwright Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
Aug 24, 2026 06:10AM EU approves Acadia's trofinetide for Rett syndrome treatment
Aug 17, 2026 06:50AM Acadia Pharmaceuticals (ACAD) PT Raised to $49 at UBS
Aug 13, 2026 06:48AM Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
Aug 6, 2026 06:56AM H.C. Wainwright Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
Aug 5, 2026 09:16AM Acadia Pharmaceuticals (ACAD) PT Raised to $37 at RBC Capital on 'Strong Sales'
Aug 5, 2026 06:33AM Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Oppenheimer
Aug 5, 2026 04:07AM Acadia Pharmaceuticals (ACAD) PT Raised to $36 at Citizens: Remains a Top Pick
Aug 5, 2026 12:52AM Acadia Pharma (ACAD) Tops Q2 EPS by 12c ; Offers Guidance
Jul 29, 2026 05:19AM Acadia Pharmaceuticals (ACAD) PT Raised to $14.50 at BofA Securities
Jul 20, 2026 04:25PM Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Stifel
Jul 20, 2026 12:25PM Mizuho n Acadia Pharmaceuticals (ACAD): 'we view risk/reward as skewed significantly to the upside'
Jun 30, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
Jun 29, 2026 07:20AM Acadia Pharmaceuticals (ACAD) PT Raised to $37 at Deutsche Bank
Jun 29, 2026 06:58AM Acadia Pharmaceuticals (ACAD) PT Raised to $36 at Canaccord
Jun 29, 2026 06:41AM Mizuho Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)
Jun 29, 2026 06:03AM Acadia Pharma (ACAD) call put ratio 6.8 calls to 1 put with a focus on July 25 calls
Jun 29, 2026 03:57AM Acadia Pharmaceuticals (ACAD) PT Raised to $35 at Citi, Opens 90-Day Upside CW
Jun 26, 2026 12:33PM Oppenheimer Reiterates Perform Rating on Acadia Pharmaceuticals (ACAD)
Jun 26, 2026 10:51AM Baird Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)
Jun 26, 2026 08:09AM Mizuho Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)
May 7, 2026 06:29AM Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
May 6, 2026 04:07PM Acadia Pharma (ACAD) Misses Q1 EPS by 3c ; Offers Guidance
Apr 7, 2026 09:08AM ACADIA Pharmaceuticals launches powder formulation of Rett syndrome drug
Mar 25, 2026 06:10AM BofA Securities Upgrades Acadia Pharmaceuticals (ACAD) to Buy
Mar 24, 2026 05:54AM RBC Capital on Acadia Pharmaceuticals (ACAD): 'Setup Skews Net Favorably'
Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
Mar 2, 2026 04:57PM Acadia Pharmaceuticals (ACAD) PT Lowered to $29 at BofA Securities
Mar 2, 2026 04:56PM Acadia Pharmaceuticals (ACAD) PT Lowered to $29 at BofA Securities
Mar 2, 2026 04:05PM Acadia Pharmaceuticals plans re-examination after EU rejection of Rett drug
Feb 26, 2026 07:51AM Acadia Pharmaceuticals (ACAD) PT Raised to $20 at Jefferies
Feb 26, 2026 06:58AM Acadia Pharmaceuticals (ACAD) PT Lowered to $33 at Citi
Feb 26, 2026 04:37AM Acadia Pharmaceuticals (ACAD) PT Raised to $35 at Citizens: Potential for Robust Growth
Feb 25, 2026 04:16PM Acadia Pharma (ACAD) Tops Q4 EPS by 146c ; Offers Guidance
Feb 24, 2026 09:01AM Wolfe Research Starts Acadia Pharmaceuticals (ACAD) at Outperform
Feb 23, 2026 03:32PM Acadia Pharma (ACAD) call put ratio 37 calls to 1 put with a focus on March calls as share price up 1.4%
Feb 23, 2026 04:41AM Mizuho Upgrades Acadia Pharmaceuticals (ACAD) to Outperform
Feb 6, 2026 06:31AM Acadia Pharmaceuticals (ACAD) PT Raised to $23 at Oppenheimer
Feb 3, 2026 08:48AM Acadia Pharmaceuticals (ACAD) PT Lowered to $31 at RBC Capital
Feb 3, 2026 06:43AM H.C. Wainwright Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
Feb 3, 2026 06:36AM Canaccord Genuity Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)
Feb 3, 2026 04:11AM Acadia Pharmaceuticals (ACAD) Reiterated at Market Outperform by Citizens
Feb 2, 2026 04:14PM ACADIA receives negative trend vote from EU regulators on Rett drug
View More Recent Stories View Older Stories